Mesenchymal stem cells (MSCs) possess great immunomodulatory capacity which lays the foundation for their therapeutic effects in a variety of diseases. Recently, toll-like receptors (TLR) have been shown to modulate MSC functions; however, the underlying molecular mechanisms are poorly understood. Emerging evidence suggests that long noncoding RNAs (lncRNAs) are an important class of regulators involved in a wide range of biological processes. To explore the potential involvement of lncRNAs in TLR stimulated MSCs, we performed a comprehensive lncRNA and mRNA profiling through microarray. 10.2% of lncRNAs (1733 out of 16967) and 15.1% of mRNA transcripts (1760 out of 11632) were significantly differentially expressed (absolute fold-change ≥5 , P value ≤ 0.05) in TLR3 stimulated MSCs. Furthermore, we characterized the differentially expressed lncRNAs through their classes and length distribution and correlated them with differentially expressed mRNA. Here, we are the first to determine genome-wide lncRNAs expression patterns in TLR3 stimulated MSCs by microarray and this work could provide a comprehensive framework of the transcriptome landscapes of TLR3 stimulated MSCs.
Introduction
Mesenchymal stem cells (MSCs) are a type of adult stem cells with the capacity to generate a wide range of cells such as adipocytes, osteoblasts, chondrocytes, and myocytes [1] . Being originally identified from the bone marrow, MSCs now can be isolated from many other tissues including adipose tissue, placenta, and umbilical cord. MSCs also possess potent immunoregulatory abilities through interactions with both the adaptive and the innate immune cells. The immunomodulatory effect of MSCs is mediated by the secretion of soluble factors and/or by cell-cell contact-dependent regulation. These features make MSCs an interesting cell resource for tissue regeneration and cellular therapy.
Recently, the findings of functional toll-like receptors (TLRs) expression on MSC implicate these receptors in modulating MSCs functions [2] . TLRs are pattern recognition receptors involved in the recognition of pathogen-associated molecular patterns (PAMP) by immune cells, initiating both primary and adaptive immune responses [3] . To date, thirteen mammalian TLR analogs have been identified (10 in humans and 13 in mice). Beside their important roles in immunity, TLRs have also been recognized as regulators of stem cells functions, including cell growth, differentiation, and survival. For instance, De Luca et al. showed that TLR1/2 signaling instructed commitment of human hematopoietic stem cells to a myeloid cell fate [4] . Qi et al. demonstrated that both TLR3 and TLR4 promoted differentiation of bone marrow MSCs to osteoblasts [5] .
In the field of immunology, recent publications have shown widespread changes in the expression of lncRNAs during the activation of the innate immune response and T cell development, differentiation, and activation [6] . It is well known that TLRs and their specific stimulus activate MyD88-dependent or -independent downstream signaling pathways. However, whether epigenetic regulators such as long noncoding RNA are involved in this process remains unclear. In this study, we determined the TLR expression profile of adipose tissue derived MSCs (AD-MSCs) and the consequences of TLR3 ligation in terms of cytokine secretion by these cells.
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To explore the potential involvement of lncRNAs in TLR stimulated MSCs, we performed comprehensive lncRNA and mRNA profiling through microarray. 10.2% of lncRNAs (1733 out of 16967) and 15.1% of mRNA transcripts (1760 out of 11632) were significantly differentially expressed (absolute fold-change ≥5, value ≤ 0.05) in TLR3 stimulated MSCs. Furthermore, we characterized the differentially expressed lncRNAs through their classes and length distribution and correlated them with differentially expressed mRNA. To the best of our knowledge, this is the first study that links TLR3 with lncRNAs in MSCs.
Materials and Methods

Isolation and Culture of AD-MSCs.
Adipose tissues were obtained from patients undergoing tumescent liposuction according to procedures approved by the Ethics Committee at the Chinese Academy of Medical Sciences and Peking Union Medical College. AD-MSCs were isolated and cultureexpanded as previously reported [1, 7] . Passage 3 cells were used for the experiments.
Adipogenic and Osteogenic Differentiation of AD-MSCs.
Adipogenic differentiation was induced in high glucose of Dulbecco's Modified Eagle's Medium (H-DMEM) supplemented with 10% FBS, 1 M dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and 5 g/mL 0.1 mM l-ascorbic acid. After being cultured in adipocyte induction medium for 4 days, medium was replaced with adipocyte maintaining medium, H-DMEM, with 10% FBS. For osteogenic differentiation, AD-MSCs were cultured in H-DMEM containing 10% FBS, 10 mM -glycerophosphate, 50 mM l-ascorbic acid, and 0.01 M dexamethasone for 14 days. (1) RNA labeling and array hybridization are as follows: sample labeling and array hybridization were performed according to the Agilent One-Color Microarray-Based Gene Expression Analysis protocol (Agilent Technology) with minor modifications. Briefly, mRNA was purified from total RNA after removal of rRNA (mRNA-ONLY Eukaryotic mRNA Isolation Kit, Epicentre). Then, each sample was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts without 3 bias utilizing a random priming method (Arraystar Flash RNA Labeling Kit, Arraystar). The labeled cRNAs were purified by RNeasy Mini Kit (Qiagen). The concentration and specific activity of the labeled cRNAs (pmol Cy3/ g cRNA) were measured by NanoDrop ND-1000. 1 g of each labeled cRNA was fragmented by adding 5 L 10× blocking agent and 1 L of 25× fragmentation buffer and then the mixture was heated at 60 ∘ C for 30 min; finally, 25 L 2× GE hybridization buffer was added to dilute the labeled cRNA. 50 L of hybridization solution was dispensed into the gasket slide and assembled to the LncRNA expression microarray slide. The slides were incubated for 17 hours at 65 ∘ C in an Agilent Hybridization Oven. The hybridized arrays were washed, fixed, and scanned using the Agilent DNA Microarray Scanner (part number G2505C). Quality control for labeling efficiency was shown in Supplementary Table 2. (2) Data analysis is as follows: slides were scanned at 5 lm/pixel resolution using an Axon GenePix 4000B scanner (Molecular Devices Corporation) piloted by GenePix Pro 6.0 software (Axon). Scanned images (TIFF format) were then imported into NimbleScan software (version 2.5) for grid alignment and expression data analysis. Expression data were normalized through quantile normalization and the Robust Multichip Average (RMA) algorithm included in the NimbleScan software. The probe level files and mRNA level files were generated after normalization. All gene level files were imported into Agilent GeneSpring GX software (version Table 1 : PCR primers specific to TLR-1 and to TLR-10.
ALP and
Gene
Sense primer (5 ∼3 ) Antisense primer (5 ∼3 )  TLR1  CCACGTTCCTAAAGACCTATCCC  CCAAGTGCTTGAGGTTCACAG  TLR2  ATCCTCCAATCAGGCTTCTCT  GGACAGGTCAAGGCTTTTTACA  TLR3  TTGCCTTGTATCTACTTTTGGGG  TCAACACTGTTATGTTTGTGGGT  TLR4  AGACCTGTCCCTGAACCCTAT  CGATGGACTTCTAAACCAGCCA  TLR5  TCCCTGAACTCACGAGTCTTT  GGTTGTCAAGTCCGTAAAATGC  TLR6  TGAATGCAAAAACCCTTCACCT  CCAAGTCGTTTCTATGTGGTTGA  TLR7  CACATACCAGACATCTCCCCA  CCCAGTGGAATAGGTACACAGTT  TLR8  ATGTTCCTTCAGTCGTCAATGC  TTGCTGCACTCTGCAATAACT  TLR9  CTGCCACATGACCATCGAG  GGACAGGGATATGAGGGATTTGG  TLR10 GGTTCTTTTGCGTGATGGAATC GGTCGTCCCAGAGTAAATCAAC 11.5.1) and normalized by the quantile method; then, Combat software was used to adjust the normalized intensity to remove batch effects. Hierarchical clustering was performed using Agilent GeneSpring GX software (version 11.5.1). The analysis was performed by KangChen Biotech., Shanghai, China. Agilent Feature Extraction software (version 11.0.1.1) was used to analyze acquired array images. We have four samples; three were control MSCs and one is TLR3-activated MSCs. LncRNAs and mRNAs that have flags in Present or Marginal (all targets value) in at least 2 out of the 3 control MSCs samples were chosen for further data analysis. Differentially expressed LncRNAs and mRNAs with statistical significance between the two groups were identified through value/FDR filtering. Hierarchical clustering and combined analysis were performed using homemade scripts. For gene ontology analysis, Fisher's exact test was used to determine whether the overlap between the differentially expressed gene list and the GO annotation list was greater than that expected by chance. The value denotes the significance of GO term enrichment in the differentially expressed genes.
Results
Characterization of AD-MSCs and the Expression Pattern of TLRs.
We isolated and expanded plastic adherent, spindle-like mesenchymal stem cells from adipose tissue (Figure 1(a) ). AD-MSCs expressed high levels of CD29, CD44, and CD105 but were persistently negative for CD31, CD34, and HLA-DR (Figure 1(b) ). Osteogenic differentiation was detected by Alizarin red staining and ALP activity assay (Figure 1(c) ). Adipogenic differentiation was demonstrated by oil red O staining (Figure 1(c) ). The expression of TLRs in MSCs remains controversial. PCR primers specific to TLR-1 and to TLR-10 were designed to detect TLRs from total RNA in AD-MSCs (Table 1) . RT-PCR results showed that all TLRs were detectable within 33 cycles and that TLR3 has the highest expression level (Figure 1(d) ).
Effect of TLR3 Agonist on Cytokine Expression of AD-
MSCs. Since TLR3 had the highest expression level, to evaluate its functionality, we stimulated AD-MSCs with TLR3 agonist (Poly I:C 20 g/mL) for 24 h and determined its effect on cell proliferation and cytokine secretion. Poly I:C slightly decreased proliferation of AD-MSCs (Figure 2(a) ). Flow cytometry analysis of cell cycles showed that Poly I:C stimulated AD-MSCs had enhanced G2 phase (Figure 2(b) ). We measured a number of cytokines known to be involved in immunomodulation, including IL-1 , IL-4,IL-6, IL-8, IL-10, IL-12, TNF-, TGF , and IFN-. We found that Poly I:C induced upregulation of IL-1 , IL-6, IL-8, and TNFas measured by RT-PCR (Figure 2(c) ). Enhanced release of these cytokines was also detected by ELISA (Figure 2(d) ). Exposure to poly (I:C) also increased the expression of TLR3 (Figure 2(e) ).
Overview of lncRNA and mRNA Profiles in TLR3-Activated AD-MSCs and Control AD-MSCs.
To examine the lncRNA expression profiles in AD-MSCs treated with or without TLR3 agonist, we used Arraystar Human LncRNA Microarray V3.0 which contains 30,586 lncRNA probes, collected from RefSeq, UCSC knowngenes, Gencode, and so forth, and 26,109 mRNA probes. The overview of lncRNA expression profiles is summarized in Table 2 and Figure 3(a) . Overall, we found that 55.5% of lncRNAs (16967 out of 30586) and 44.5% of protein-coding mRNA transcripts (11632 out of 26109) on the microarray exhibited expression above background. 10 TLR1  TLR2  TLR3  TLR4  TLR5  TLR6  TLR7  TLR8  TLR9  TLR10  GAPDH   TLR and control AD-MSCs. The top 10 up-and downregulated LncRNAs in TLR3-activated AD-MSCs compared to control AD-MSCs were shown in Table 3 . Figure 3(b) showed the hierarchical cluster of lncRNAs expression in Poly I:C stimulated AD-MSCs and nonstimulated AD-MSCs. Additionally, statistical analysis showed that the expressed lncRNAs were widely distributed on all chromosomes (Figure 3(c) ) and that chr1 had the most expressed lncRNAs, while the mitochondrial genome had the least.
Characteristics of LncRNAs with Changed Expression in TLR3-Activated AD-MSCs.
Among the 7271 differentially expressed LncRNA (absolute fold-change ≥2, value ≤ 0.05), 2155 lncRNAs were upregulated in experimental group compared to the control group, while 5116 lncRNAs were downregulated. Here, one upregulated lncRNA uc010kun.2 was of particular interest for us because it is located upstream of IL6, a cytokine induced after TLR3 activation in ADMSCs. Using qPCR, we observed a 2.70-fold upregulation in Stem Cells International 7 Figure 1) . Table 3 showed the top 10 up-and downregulated lncRNAs in TLR3-activated AD-MSCs versus control AD-MSCs. We classified these differentially expressed LncRNAs into 6 groups: "senseoverlapping," the LncRNA's exon is overlapping a coding transcript exon on the same genomic strand; "intronic," the LncRNA is overlapping the intron of a coding transcript on the same genomic strand; "natural antisense," the LncRNA is transcribed from the antisense strand and overlapping with a coding transcript; "nonoverlapping antisense," the LncRNA is transcribed from the antisense strand without sharing overlapping exons; "bidirectional," the LncRNA is oriented head to head to a coding transcript within 1000 bp; "intergenic": there are no overlapping or bidirectional coding transcripts nearby the LncRNA. Figure 4(a) showed the distribution of the six classes of LncRNAs with changed expression in TLR3-activated AD-MSCs. The lncRNAs are mainly between 200 bp and 3000 bp in length. Figure 4(b) showed the length distribution of differentially expressed lncRNAs. The majority of the differentially expressed lncRNAs have a length between 500 bp and 1000 bp.
Gene Ontology and Pathway
Analysis. GO analysis was performed to determine the gene and gene product enrichment in biological processes, cellular components, and molecular functions (Supplementary Figure 2) . We found that the highest enriched GOs targeted by upregulated mRNAs in TLR3-activated MSCs were mRNA metabolic process (ontology: biological process) ( Figure 5(a) ), intracellular part (ontology: cellular component) ( Figure 5(b) ), and structural constituent of ribosome (ontology: molecular function) ( Figure 5(c) ). The highest enriched GOs targeted by the downregulated transcripts in TLR3-activated MSCs were response to external stimulus (ontology: biological process) ( Figure 5(d) ), ankyrin binding (ontology: cellular component) ( Figure 5 (e)), and intrinsic to plasma membrane (ontology: molecular function) ( Figure 5(f) ). Specifically, we analyzed expression of genes associated with immune response (GO:0006955 Figure 6(a) ), genes associated with immune response-regulation signaling pathway (GO:0002764 Figure 6 (b)), and genes associated with regulation of immune response (GO:0050776 Figure 6 (c)). Additionally, other genes associated with immune response (GO:0050778, GO:0042092, GO:0002828, GO:0002920, and GO:0002821) were analyzed (Supplementary Figure 3) . Pathway analysis indicated that 38 pathways were upregulated and 31 were downregulated in TLR3-activated MSCs. Figure 7 showed the top 10 of the changed pathways.
Discussion
TLRs play an important role in innate and adaptive immunity. The expression and function of multiple TLRs have been described in many cell types, especially in cells of the innate immune system, where they function as sensors of infection or damage [8, 9] . However, conflicting results have been reported because TLRs expressed on different cell types from different species and tissues resulted in different responses [10] . Recently, it has been reported that MSC derived from adult bone marrow also expresses functional TLRs that promote their survival and proinflammatory cytokine secretion [11] . Here, we show that AD-MSCs express 10 types of TLRs and the expression level of TLR3 was the highest. Activation of TLR3 in AD-MSCs leads to enhanced secretion of IL-1 , IL-6, IL-8, and TNF-. It is well known that TLRs and their specific stimulus activate MyD88-dependent or -independent downstream signaling pathways. However, whether epigenetic regulators such as long noncoding RNA are involved in this process remains unclear. lncRNAs are over 200 nucleotides in length and are separate from the other known ncRNA subsets. Previous studies have focused primarily on short noncoding RNAs, such as microRNAs, transfer RNAs, and short interfering RNAs. Increasing evidence confirmed lncRNAs to be one of the most important factors controlling gene expression and the aberrant expression of which is involved in a variety of human diseases, including immunological disorders [12, 13] . Guttman et al. were the first to use the intergenic deposition of epigenetic marks to identify 20 lncRNAs induced in lipopolysaccharide-(LPS-) stimulated mouse bone marrowderived dendritic cells (BMDD) [14] . Later on, several lncRNAs have been identified following activation of monocytes, macrophages, fibroblasts, and dendritic cells [15] [16] [17] [18] . The potential importance of lncRNAs in the immune response is only now emerging. Immune-related lncRNAs are generally identified through examination of differential expression in response to activation of immune cells [6] . Here, a major focus of our study was to define the repertoire of lncRNAs in TLR3-activated AD-MSCs. We performed comprehensive lncRNA and mRNA profiling through microarray and found transcripts (1760 out of 11632) were significantly differentially expressed in TLR3 stimulated MSCs. Furthermore, we characterized the differentially expressed lncRNAs through their classes and length distribution and correlated them with differentially expressed mRNA. An interesting observation from sequencing data is that many of the immune-related lncRNAs are located close to, or partially overlapping, the 5 end (upstream) or 3 end (downstream) of protein-coding genes implicated in the immune response [6, 19] . Here, one upregulated lncRNA uc010kun.2 was of particular interest for us because it is located upstream of IL6, a cytokine induced after TLR3 activation in AD-MSCs. Another lncRNA our data may highlight is lncRNA-Cox7A2. Carpenter et al. indicated that Cox2 and lncRNA-Cox2 regulated by MyD88 and NF-kB were markedly induced after TLR4 stimulation in BMDMs [17] . Here, lncRNA-Cox7A2 is predicted to be associated with Cox7A2, which is also a cytochrome c oxidase subunit.
TLR3 signaling and subsequent inflammatory responses are controlled by a multitude of regulatory molecules. Here, we propose a model whereby TLR3 signaling induces expression changes of lncRNAs which then exert their effects as repressors or activators of genes through interactions with various regulatory complexes. As such, lncRNAs represent a new component of the TLR3 signaling pathway.
In summary, our study was the first to demonstrate that a set of lncRNAs is significantly regulated in AD-MSCs upon stimulation with TLR3, suggesting a role of lncRNAs in the immune response of AD-MSCs. This will provide the basis for the subsequent functional and mechanistic analysis of individual lncRNAs. Currently, the precise functions of the differentially expressed lncRNAs remain largely unknown 10 Stem Cells International   CD81  IFITM1  CLEC10A  TNFSF4  HLA-DRB4  CCL5  HCST  COL3A1  FCGR2C  MASP2  IFNAR2  SPPL2B  RPS6KA2  HMOX1  NCR1  RARA  COL4A3BP  CXCL12  FCAR  MEF2C  CAMK2B  MAPK3  ZP3  GATA3  CD1E  HLA-DQB2  C2  PGLYRP4  TNFSF10  PCBP2  CCR9  CREBBP  RAET1G  NCF4  ENPP2  CD70  PRKRA  SBNO2  HLX  CTLA4  IL12RB1  CAPZA2  MAP2K4  HFE  AXL  CAMK2D  IL1RAP  CD46  IP6K2  NLRP1  OTUD5  SEMA4A  ELK1  CCL25  CD3E  PML  ELANE  IL-9  LILRA5  TRAF3  CREB1  CD200  OSM  MNX1  CST7  GPI  TP53  CRHR1  C8G  TLR5  CCL18  NLRP3  TNF  IL18R1  TCF7  CD274  UNC13D  CCR2  RELA  HLA-DMB  PIK3CD  NCKAP1L  PIK3R1  RNASE7  BLNK  CCL14  CFHR5  PTK2B  ARRB2  BCAR1  NCK1  PIK3R2  SIRT1  GP2  CASP8  TRIL  CCR8  CFI  RIPK1  PTGER4  IL25  CD1C  CHIT1  SLC30A8  NCF2  LILRB2  TDGF1  IL21  ULBP1  TAB3  HAMP  KIR2DL1  CD34  HPX  KIR2DL4  C4A  CD4  STAT6  IRAK2  ULBP3  CXCL11  FCGR1B  CXCL10  CNR1  POLR3A  IL18  MADCAM1  VTN  PRKCZ  LIME1  SEMA3C  TLR3  CCL1  AIF1  ICAM2  CFHR1  SEMA4D GO:0006955 3 4 5 6 7 8 9 Poly I:C Control ELANE  TRAF3  CREB1  TNF  C8G  CRHR1  TLR5  UNC13D  CCR2  LILRB2  CNR1  RELA  IRAK2  ULBP3  FCGR1B  CFI  RIPK1  CD34  HPX  CD4  STAT6  KIR2DL4  C4A  IL21  ULBP1  TAB3  KIR2DL1  HLA-DMB  PIK3R1  NCKAP1L  PIK3R1  CFHR5  NFKBIL1  NCK1  PIK3R2  SIRT1  CASP8  TRIL  ARRB2  CD200  BCAR1  CD46  CCL5  HCST  COL3A1  MASP2  IFNAR2  CD81  IFITM1  TNFSF4  HLA-DRB4  HMOX1  NCR1  RARA  RPS6KA2  MAPK3  ZP3  GATA3  MEF2C  HLX  CTLA4  IL12RB1  MAP2K4  HLA-DQB2  C2  TESPA1  SPPL2B  CD3E  PRKCZ  LIME1  MADCAM1  TLR3  ICAM2  CFHR1  ELK1   GO: and advances in the understanding of their role will allow us to tackle a range of challenges in AD-MSCs immunomodulatory properties.
Highlights
(1) TLR3 is highly expressed in adipose tissue derived mesenchymal stem cells. 
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